In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Quest Diagnostics yesterday announced the launch of a new diagnostic test for Oropouche virus, a disease primarily spread by ...

Tocilizumab significantly reduced 28-day mortality and length of ICU stay in patients with severe COVID-19 pneumonia and low S-spike nAb titers.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical ...

Market OverviewThe global Epilepsy Drugs Market is valued at USD 10.63 billion in 2024 and is projected to reach a value ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we ...

This systematic review and meta-analysis confirms modest efficacy of infliximab for pulmonary sarcoidosis and highlights promising but limited evidence for adalimumab, tofacitinib and efzofitimob in ...

There will probably never be a perfect treatment to cure COVID-19—but the right medications for the right patients can save lives.

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...